Table 2 Immunohistochemical findings.
From: Recurrent novel THBS1-ADGRF5 gene fusion in a new tumor subtype “Acral FibroChondroMyxoid Tumors”
CD34 (%) | ERG (%) | SOX9 (%) | PS100 (%) | P63 (%) | EMA (%) | AE1/AE3 (%) | SMA (%) | SOX10 (%) | Ki67 (%) | |
|---|---|---|---|---|---|---|---|---|---|---|
Case 1 | +F | +D | +D | +F | – | – | – | – | – | <5 |
Case 2 | +F | – | +F | +F | – | – | – | – | NA | NA |
Case 3 | +F | +F | +F | – | – | – | – | – | – | <5 |
Case 4 | +F | +F | +F | +F | – | – | – | – | – | <5 |
Case 5 | +F | +D | +F | – | – | – | – | – | – | <5 |
Case 6 | +D | +F | – | +F | – | – | – | – | – | <5 |
Case 7 | +F | +D | +D | +F | +F | – | – | – | – | <5 |
Case 8 | +F | +D | +F | – | – | +F | – | – | – | <5 |
Case 9 | +F | +F | – | – | – | – | – | – | – | <5 |
Case 10 | +D | +F | – | – | +F | – | – | – | – | <5 |
Positive cases | 10 (100) | 9 (90) | 7 (70) | 5 (50) | 2 (20) | 1 (10) | 0 (0) | 0 (0) | 0 (0) | <5 |
Focal | 8 (80) | 5 (50) | 5 (50) | 5 (50) | 2 (20) | 1 (10) | 0 (0) | 0 (0) | 0 (0) | |
Diffuse | 2 (20) | 4 (40) | 2 (20) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
